Evidence map›Paper›PMID 39796709›Full record

ArticleCancers2024

miR-217-5p NanomiRs Inhibit Glioblastoma Growth and Enhance Effects of Ionizing Radiation via EZH2 Inhibition and Epigenetic Reprogramming.

Jack Korleski, Sweta Sudhir, Yuan Rui, Christopher A Caputo, Sophie Sall, Amanda L Johnson, Harmon S Khela, Tanmaya Madhvacharyula, Anisha Rasamsetty, Yunqing Li and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jack KorleskiHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.ORCID 0000-0003-3845-7869
Sweta SudhirHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
Yuan RuiDepartment of Biomedical Engineering, Institute for NanoBioTechnology, Baltimore, MD 21205, USA.
Christopher A CaputoHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
Sophie SallHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
Amanda L JohnsonHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.ORCID 0000-0002-3055-945X
Harmon S KhelaHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
Tanmaya MadhvacharyulaHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
Anisha RasamsettyHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
Yunqing LiHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.ORCID 0000-0002-9679-505X
Bachchu LalHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
Weiqiang ZhouDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0001-9396-9571
Karen Smith-ConnorHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
Stephany Y TzengDepartment of Biomedical Engineering, Institute for NanoBioTechnology, Baltimore, MD 21205, USA.ORCID 0000-0002-7561-482X
Jordan J GreenDepartment of Biomedical Engineering, Institute for NanoBioTechnology, Baltimore, MD 21205, USA.
John LaterraHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
Hernando Lopez-BertoniHugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.ORCID 0000-0001-6618-1092

Funding

Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Stewart H Mostofsky · 2020 to 2026
$9.9M
Chromatin Modifications in GBM-Propagating CellsR01NS096754 · NINDS · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI LATERRA, JOHN J · 2017 to 2021
$2.2M
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.R01NS120949 · NINDS · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI LOPEZ-BERTONI, HERNANDO MARTIN · 2021 to 2025
$2.0M
Gene Delivery Nanoparticles to Treat GlioblastomaR01EB016721 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI GREEN, JORDAN · 2013 to 2017
$1.9M
Zeiss LSM780 Confocal Microscope for a Core FacilityS10OD016374 · OD · JOHNS HOPKINS UNIVERSITY · PI KUO, SCOT CHARLES · 2013 to 2013
$584k
NIBIB NIH HHS R01 EB016721NICHD NIH HHS P50 HD103538NIH HHS 1R01NS120949-04A1NIH HHS S10 OD016374NINDS NIH HHS R01 NS096754NINDS NIH HHS R01 NS120949
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

epigeneticsEZH2GBMmiRNAsnanoparticlestargeted therapies

Identifiers

PMID39796709
PMCPMC11719642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.